Arensia Clinics S.R.L. — Clinical Trial Site

32 Registered trials

14 Currently recruiting

Organisation

Arensia Clinics S.R.L.

Location

Bucharest, Romania

Identifier

ORG-100052806

Address

Intrarea Tudor Stefan 38-40, 011658, Romania

Departments

3001: Nephrology
3701: Ophthalmology
3rd Floor, Wards 1, 2, 3, 4, 5, 6 and 7
4001: Gastroenterology
6001: Internal Medicin
6101:
6119: Pulmonology
642002: Orthopaedics & Traumatology
AEM in colab. with Arensia Clinics, 3rd floor, Wrds 1,2,3,4,5,6,7,Tudor Stefan Str,Bucharest
Arensia Clinics S.R.L.
ARENSIA Clinics S.R.L., 3rd floor-, and wards 1, 2, 3, 4, 5, 6 and 7
ARENSIA Exploratory Medicine S.R.L in collaboration with ARENSIA Clinics SRL
Cardiology
Clinical Hematology
Dermatology
Gastroenterology
Gastroenterology and Hepatology
Internal Medcine
Internal Medicine
Internal Medicine Department
Medical
Neurologie
Neurology
Oncology
Ph. I Unit-ArensiaEM in collab. with Arensia Clinics, 3rd Floor, Wards 1,2,3,4,5,6 and 7
Pneumology
Research Facility
Rheumatology

Clinical trials at this site (32)

Search interface

A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate… Pending

2025-520978-18-00 Chronic Kidney Disease 1
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants Pending

2025-521758-40-00 Geographic Atrophy 1
Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis Pending

2025-523678-17-00 rheumatoid arthritis 3
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio… Pending

2025-523704-77-00 Geographic atrophy secondary to age-related macular deg 4
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy o… Pending

2025-525113-22-00 Rheumatoid Arthritis 1
A Multi-Stage Study to Test a New Drug in Healthy Adult Volunteers, Then in Adults with Ulcerative Colitis Recruiting

2025-522702-21-00 Ulcerative Colitis is a type of inflammatory bowel dise 4 2026-01-26
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a… Recruiting

2024-520196-27-00 Rheumatoid Arthritis 3 2025-10-01
A phase 1 trial to evaluate the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in participants with … Recruiting

2024-518976-30-00 Systemic lupus erythematosus 3 2025-07-02
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-… Recruiting

2024-511346-39-00 Immune-mediated necrotizing myopathy 3 2025-03-28
A Phase 1, dose determining study of EXS73565 in participants with relapsed or refractory B‑cell malignancies. Recruiting

2024-516869-36-00 Relapsed or refractory B-cell malignancies: chronic lym 1 2025-02-17
A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004) Recruiting

2025-523412-36-00 Systemic lupus erythematosus, Rheumatoid arthritis 3 2026-02-17
A Phase 1b open label pilot study of CLN-978 for the treatment of moderate to severe systemic lupus erythematosus (SLE) Recruiting

2024-518780-36-00 Systemic Lupus Erythematosus 3 2025-12-10
REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting

2025-520478-20-00 Thromboembolic disease 5 2025-11-05
A Phase 1 Study of WVE-007 in Adults Living with Overweight or Obesity Recruiting

2024-520203-41-00 Adults Living with Overweight and Obesity 1 2025-07-25
Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Recruiting

2024-513959-33-00 Asthma 4 2025-05-13
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 Bullous pemphigoid 3 2024-08-22
Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults with Active Sjögren’s Syndrome Recruiting

2023-503327-26-00 Sjogren's syndrome 5 2024-01-31
A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma C… Recruiting

2024-515273-10-00 Relapsed or refractory Multiple Myeloma (r/r MM) 7 2021-10-19
A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 following Intravenous a… Recruiting

2023-509357-31-00 Multiple Sclerosis (MS) 1 2021-06-01
A trial to explore the efficacy and safety of IDOR-1117-2520 in adults with moderate to severe chronic plaque psoriasis, with or without pso… Ended

2025-523051-64-00 Moderate to severe chronic plaque psoriasis 4 2026-01-26
A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692… Ended

2024-512914-16-00 Relapsing-remitting Multiple Sclerosis 5 2025-09-12
Assessment of Pharmacokinetic Similarity of FYB206 in Comparison with Keytruda in Resected Stage II or Stage III Melanoma Patients Ended

2023-509765-20-00 Melanoma: Adjuvant treatment of patients with Stage IIB 2 2024-10-21
A Double-blind, Randomized, Active-controlled, Parallel-group, Phase 1/3 study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and S… Ended

2022-501622-37-00 Multiple Sclerosis 5 2024-01-16
Dose-finding study of SAR443122 in adult participants with ulcerative colitis Ended

2022-500290-14-01 Colitis ulcerative 4 2023-05-11